Kalyan Roy: Platelet Satellitism – An Important Laboratory Artifact
Kalyan Roy, Transfusion Medicine Specialist at Square Hospitals LTD, shared a post on LinkedIn:
“Platelet Satellitism: An Important Laboratory Artifact
What is Platelet Satellitism?
Platelet satellitism is an EDTA-dependent in vitro phenomenon in which platelets adhere to and surround neutrophils in anticoagulated blood samples.
This interaction can lead to pseudothrombocytopenia, resulting in falsely low platelet counts on automated analyzers.
Underlying Mechanism
- EDTA induces structural changes on platelet and neutrophil membranes
- These changes expose binding sites
- Circulating antibodies or plasma proteins facilitate platelet adhesion to neutrophils
Why It Matters
- Causes spurious thrombocytopenia
- May lead to unnecessary investigations or treatment if unrecognized
How to Identify It
- Review a peripheral blood smear
- Look for platelets rosetting around neutrophils
- Correlate with analyzer flags or unexpected low platelet counts
Recommended Approach
Repeat sample collection using alternative anticoagulants:
- Sodium Citrate
- Heparin
Compare platelet counts to confirm EDTA-related artifact
Associated Conditions
Platelet satellitism may be observed in:
- Autoimmune disorders (e.g., SLE)
- Chronic infections or inflammatory states
- Hematologic malignancies (e.g., leukemia, lymphoma)
- Presence of antiplatelet antibodies
Key Takeaway
Platelet satellitism is a laboratory artifact, not a true thrombocytopenia.
Awareness and proper verification are essential to avoid misdiagnosis and ensure accurate patient care.”
Stay updated with Hemostasis Today.
-
Sep 16, 2026, 16:06Katrina Louise Manalaysay: In Your 20s, You Might be Given the Opportunity to Donate Blood for the First Time
-
Sep 16, 2026, 15:45Matthew Hazell: A Brilliant Explanation of Phenotype vs Genotype Using a LEGO House
-
Sep 16, 2026, 15:23Ahmad Al-Ramahi: Presenting the Military Pharmacists Blood Training Course at the FIP World Congress
-
Sep 16, 2026, 15:21HIT Reimagined: Can 12-Lipoxygenase Inhibition Stop Immune Thrombosis?
-
Sep 16, 2026, 14:42Ruchi Punamia: Beyond the Blood Bank and The Clinical Impact of Apheresis
-
Sep 16, 2026, 14:06Kalyan Roy: Celebrating Apheresis, Advancing Care, Saving Lives
-
Sep 16, 2026, 13:38Andrew Zapfel: Advancing Sickle Cell Disease Care and Research
-
Sep 16, 2026, 13:30Thirunavukkarasu Angappan: Why Plasma-Derived Factor VIII Still Matters for Inhibitor Patients
-
Sep 16, 2026, 13:22Matthew Hazell: New BSH Guidance for Fetal, Neonatal and Paediatric Transfusion